EXHIBIT 99.1

                     PRESS RELEASE DATED SEPTEMBER 24, 1999



GISH BIOMEDICAL ANNOUNCES STREAMLINING OF WORK FORCE

Irvine, California-September 24, 1999-The Board of Directors of Gish Biomedical,
Inc.  (Nasdaq:GISH)  today  announced a 23%  reduction  in its work  force.  The
Company is  continuing to evaluate all possible  further cost savings  measures.
These moves are steps to increase Gish's competitive position in the marketplace
and to decrease its overhead and production  costs.  Severance  costs related to
the reduction in personnel of approximately  $100,000 are expected to be charged
to operations in the quarter ending September 30, 1999.












Gish Biomedical designs and manufactures  disposable medical devices for various
surgical  specialties  including   cardiovascular  surgery,   orthopedics,   and
oncology.   Currently  there  are  3,473,862   shares  of  Gish's  common  stock
outstanding.

This news release contains  forward-looking  statements concerning the Company's
business  and  products.  Actual  results may differ  materially  depending on a
number of risk factors,  including the impact of competition,  downward  pricing
pressures in the relevant markets,  risks related to product performance and the
risks relating to consumer acceptance of the Company's products. These and other
risks  inherent  in the  Company's  business  are  described  in  the  Company's
Securities and Exchange Commission filings,  including its Annual Report on Form
10-K.  The  Company  undertakes  no  obligation  to revise  the  forward-looking
statements  contained herein to reflect events or  circumstances  after the date
hereof or to reflect the occurrence of unanticipated events.